Epstein Secrets

7, Kusisto, Frosch, Subscription Publication, 7.57M) reports Floyd's death has also prompted the reexamination of older cases by local prosecutors. Crowley Says Trump's Mt. Rushmore Speech Was "Absolutely Necessary." Assistant Treasury Secretary for Public Affairs Monica Crowley said on WOR-AMVI New Yor

shown to be effective in clinical trials." CNN (7/7, Cohen, Bonifield, 83.16M) reports on its website that Novavax CEO/President Stanley Erck "said Novavax's vaccine could be on the market by the first quarter of next year." The Hill (7/7, Budryk, 2.98M) reports that "the award will also cover a large-

rnment To Pay $1.6B For Rush Vaccine Development. The CBS Evening NewsVi (7/7, story 3, 1:40, O'Donnell, 4.24M) reported, "Maryland biotech company Novavax is in the hunt for a coronavirus vaccine, and getting a major dose of funding from the government's Operation Warp Speed program." The New York lime

y served under President Obama." The New York Times <https://www.nytimes.com/2020/11/23/us/politics/biden-nominees.html> (11/23, Al, EFTA00137300 Crowley, 18.61 M) reports Haines "served as deputy director of the C.I.A. in the Obama administration before succeeding Mr. Blinken as Mr. Obama's deputy na

ted by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behi

table for their diverse personal backgrounds, but all with something in common. They served under President Obama." The New York Times (11/23, Al, Crowley, 18.61M) reports Haines "served as deputy director of the C.I.A. in the Obama administration before succeeding Mr. Blinken as Mr. Obama's deputy na

ed by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behin